Loading stock data…
BCPC
$161.52-0.10 (-0.06%)
Market ClosedLast close May 1
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Balchem Corporation in the Basic Materials sector is trading at $161.52. The stock is currently 12% below its 52-week high of $183.90, remaining 0.5% above its 200-day moving average. Technical signals show oversold RSI of 26 and bearish MACD signal, explaining why BCPC maintains its current momentum and trend strength. The Whystock Score of 85/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Oversold momentum (RSI 26) — potential for technical mean-reversion
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$161.52
Potential Downside
45%
Whystock Fair Value$88.78
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus4 analysts
Buy
Mean target$200.50+24.1%
Range$163.00 – $234.00
Fundamentals
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It o...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.67B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
36.88
Beta
Defensive asset. Lower volatility than the S&P 500.
0.95
Div Yield
Strong income play. Yield provides a meaningful total return floor.
55.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
11.35%
Volume
Today's trading volume
248,178
Recent News
Balchem Corporation Q1 2026 Earnings Call Summary
Moby summary of Balchem Corporation's Q1 2026 earnings call
Balchem (BCPC) Q1 2026 Earnings Transcript
The first quarter of 2026 was the twenty-seventh consecutive quarter of quarterly year-over-year growth in adjusted EBITDA for Balchem Corporation. Before we get into more detail on the quarter, I would like to make a few comments about the overall market environment, including the evolving geopolitical and macroeconomic situation, as well as some of the progress we have made on several important strategic initiatives.
Balchem (BCPC) Valuation Check After Steady Fundamentals And Recent Share Price Gains
Balchem stock moves after recent performance signals Balchem (BCPC) has drawn fresh attention after a period of solid reported fundamentals, with annual revenue of US$1.04b and net income of US$154.85m, alongside steady returns over the past year and past 3 months. See our latest analysis for Balchem. Balchem’s recent share price move to US$175.12 comes with a 4.9% 30 day share price return and a 13.7% year to date share price return. The 5 year total shareholder return of 34.6% points to...
Conestoga Capital Dumps 7.3 Million CCC Intelligent Solutions Shares Worth $47.8 Million
CCC Intelligent Solutions delivers cloud-based software and AI-driven tools for the insurance and automotive industries.
Conestoga Sells 64K Q2 Shares
Q2 Holdings delivers cloud-based digital banking platforms to regional and community financial institutions across the U.S.